Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria.
about
DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma.Smoking, an additional risk factor in elder women with primary open-angle glaucoma.Hemoglobin expression and regulation in glaucoma: insights into retinal ganglion cell oxygenation.Renin-angiotensin system regulates neurodegeneration in a mouse model of normal tension glaucoma.Brimonidine prevents neurodegeneration in a mouse model of normal tension glaucoma.Neuroprotection of a novel cyclopeptide C*HSDGIC* from the cyclization of PACAP (1-5) in cellular and rodent models of retinal ganglion cell apoptosisOxygen saturation measurements of the retinal vasculature in treated asymmetrical primary open-angle glaucoma using hyperspectral imagingThe immune response in glaucoma: a perspective on the roles of oxidative stressEndothelin B receptors contribute to retinal ganglion cell loss in a rat model of glaucoma.Brimonidine blocks glutamate excitotoxicity-induced oxidative stress and preserves mitochondrial transcription factor a in ischemic retinal injury.Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis.Regional choroidal blood flow and multifocal electroretinography in experimental glaucoma in rhesus macaques.Oxidative stress, mitochondrial dysfunction and calcium overload in human lamina cribrosa cells from glaucoma donorsDoes optic nerve head surface topography change prior to loss of retinal nerve fiber layer thickness: a test of the site of injury hypothesis in experimental glaucoma.Rat, mouse, and primate models of chronic glaucoma show sustained elevation of extracellular ATP and altered purinergic signaling in the posterior eye.Ginkgo biloba: an adjuvant therapy for progressive normal and high tension glaucoma.Measurement of Systemic Mitochondrial Function in Advanced Primary Open-Angle Glaucoma and Leber Hereditary Optic Neuropathy.Protective Effect of ALA in Crushed Optic Nerve Cat Retinal Ganglion Cells Using a New Marker RBPMS.Protective effects of lipoic acid on chrysene-induced toxicity on Müller cells in vitro.Antioxidant Treatment Limits Neuroinflammation in Experimental Glaucoma.Botanical compounds: effects on major eye diseasesMitochondria-Targeted Antioxidant SS-31 is a Potential Novel Ophthalmic Medication for Neuroprotection in Glaucoma.Increased malondialdehyde concentration and reduced total antioxidant capacity in aqueous humor and blood samples from patients with glaucomaBcl-2, Bcl-xL, and p-AKT are involved in neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucomaEffect of alpha lipoic acid on retinal ganglion cell survival in an optic nerve crush modelHigh Pressure-Induced mtDNA Alterations in Retinal Ganglion Cells and Subsequent Apoptosis.Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stress-mediated mitochondrial alteration in a mouse model of glaucoma.Emerging drugs for ocular hypertension.Intrinsic axonal degeneration pathways are critical for glaucomatous damage.Management of glaucoma as a neurodegenerative disease.Targeting mitochondrial function to protect against vision loss.Blue light stress in retinal neuronal (R28) cells is dependent on wavelength range and irradiance.Edaravone suppresses retinal ganglion cell death in a mouse model of normal tension glaucoma.Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma.S-adenosyl-L-methionine restores photoreceptor function following acute retinal ischemia.Association of SOD2 Mutation (c.47T > C) with Various Primary Angle Closure Glaucoma Clinical Indices.Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide.Overexpression of parkin protects retinal ganglion cells in experimental glaucoma.Nitric oxide potentiates TNF-α-induced neurotoxicity through suppression of NF-κB.Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma.
P2860
Q30663502-5C52CFC3-77E7-4837-B0A9-C7202DCD713CQ33574067-973B6C1A-BD1A-40E2-A8E3-71BD97561F1DQ33845331-DC7A86CF-43D2-4FF7-A809-1A3BF9FE0F79Q34007779-F1EE4D64-1FBF-4465-8982-0B2DE2B2A019Q34007825-65BAC8AD-D278-44DD-8B70-23963A642CC6Q34294531-8F12BFF7-4765-45E9-9CED-39F09E449A66Q34325584-D05E7303-9A8E-4182-A219-3E76185B123BQ34388254-195422B9-EBCC-46D4-86AA-BE9882FFF8FDQ34391403-25A9EAFB-3C4A-45AF-BB27-43C43A4F8816Q34442818-3E8519A8-9E2F-4B89-8D88-67B28CE6ED11Q34530196-1E1C3845-63CB-4F1D-8959-F5A066E94503Q34623942-38E6564F-C9DC-457E-A28D-EFCCD6D15E5DQ35007216-CF1AFC04-71A6-4EC1-875D-504E9A20D0D1Q35035689-70F27B23-C463-4587-8944-2AB7446AFE0EQ35629172-C0F0057F-3967-4AE8-82C4-90B4A23CD03CQ35768472-DCB9E926-2FB3-431F-9A22-EA942909C8FAQ35819272-CD15B8E2-05A4-43C7-BFEA-A1A6035B69A3Q36098534-731AE0C6-FDC9-45FE-B876-E875D0805D71Q36521057-9E9BABEE-EE50-4318-9759-EF643DB6FBAEQ36867011-73749F9F-D746-4755-8F4D-3ED42A53B724Q36988482-A611F75B-DF76-4374-841F-A74B82CA4B4BQ37038452-D6FA5A94-71B3-4781-8AD7-6F8AC11BA471Q37091567-15C55EDC-0BE0-46AB-BEEC-0A2E12A6BDB4Q37187224-3A36AE99-3C0F-48F1-A5E0-96AE224FC5D3Q37292713-2B9B0536-BA02-402C-90D5-D7E806AF3B81Q37433859-23E1350D-6478-4082-99EF-A3411FA9B080Q37593019-94F003A9-F5C3-4A58-9DC7-D58EF285EB6EQ37847182-B1CE4E6C-D804-4AF4-A4CA-7B693A22C314Q37979549-DF3AFC62-1E96-4995-AFC5-D342E89A68EDQ38679475-3FF974CB-7056-410E-9902-F74F41A86E49Q38694794-4BCF536F-96D2-4173-8F03-2621BF83F01BQ39502414-BE30E867-1F39-4E4A-8AA7-90296F28C44DQ41335619-DCDEB1F9-E127-44D2-BD63-CC46A0DD85FFQ41882390-7A8BFED7-B7BF-4B1A-98B0-B7251E9E6323Q43240395-580B8CFB-2749-4947-BC0B-D73492168728Q43856521-C03E4B25-F173-40B2-9C80-A16F9B26051FQ44908210-749C4C9F-7134-4392-BC2B-8288A42B6DB0Q47549102-10A9C4B9-F8B9-4889-9189-FF179199DC92Q48953762-43C20112-C5EF-4868-B527-B0F708D06560Q51747222-C45998E2-6684-44CC-9106-2BA450988890
P2860
Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Pathogenesis of ganglion "cell ...... lion cell axonal mitochondria.
@en
Pathogenesis of ganglion "cell ...... lion cell axonal mitochondria.
@nl
type
label
Pathogenesis of ganglion "cell ...... lion cell axonal mitochondria.
@en
Pathogenesis of ganglion "cell ...... lion cell axonal mitochondria.
@nl
prefLabel
Pathogenesis of ganglion "cell ...... lion cell axonal mitochondria.
@en
Pathogenesis of ganglion "cell ...... lion cell axonal mitochondria.
@nl
P1476
Pathogenesis of ganglion "cell ...... lion cell axonal mitochondria.
@en
P2093
Neville N Osborne
P304
P356
10.1016/S0079-6123(08)01124-2
P577
2008-01-01T00:00:00Z